Tetracaine Hydrochloride
Brand Names: Tetracaine Hydrochloride Generic
Methodology & AI Transparency ⓘ
Tetracaine Hydrochloride Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Tetracaine hydrochloride ophthalmic solution, 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic.
- 2 Real-world patient consensus: Tracked across 19 patient dosage logs with a 83% satisfaction benchmark (RxCUI 1547771).
- 3 Typical cash cost range: Uninsured 30-day outlay compares $170.22 cash mean against $417.04 retail pharmacy pricing.
- 4 Top reported side effects / signs: Key post-marketing and trial adverse reactions (Tetracaine Hydrochloride): application-site irritation (6.7%), nausea (9.2%), headache (8.5%).
Ask our AI Specialists anything about Tetracaine Hydrochloride
Tetracaine Hydrochloride Mechanism, CYP450 Pathways & DailyMed Monograph
Tetracaine hydrochloride ophthalmic solution, 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. Tetracaine hydrochloride ophthalmic solution, 0.5%, is an ester local anesthetic indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. (1)
12.1 Mechanism of Action Tetracaine blocks sodium ion channels required for the initiation and conduction of neuronal impulses thereby affecting local anesthesia.
Pharmacokinetic profiling of Tetracaine Hydrochloride demonstrates an elimination half-life of Approximately 6–11 hours terminal plasma half-life for Tetracaine Hydrochloride with Estimated 61%–73% oral systemic absorption for Tetracaine Hydrochloride systemic bioavailability; clearance proceeds via phase i/ii hepatic conjugation of tetracaine hydrochloride coupled with glomerular and tubular renal excretion, reaching clinical onset within peak plasma concentration (tmax) reached 1–4 hours post-dose for tetracaine hydrochloride.
Titration schedules for Tetracaine Hydrochloride (5 mg/mL Solution → 5 mg/mL Solution/ Drops) require excluding tetracaine hydrochloride ophthalmic solution, 0.5% should not be used in patients with a history of hypersensitivity to any component of this preparation.; tetracaine hydrochloride ophthalmic solution, 0.5% should not be used in patients with a history of hypersensitivity to any component of this preparation.; real-world patient logs highlight nausea (9.2% of reports), headache (8.5% of reports), dizziness (6.9% of reports) alongside a 83.00% Worth-It consensus.
Assess baseline hepatic panels and interacting prescriptions when starting Tetracaine Hydrochloride (ester local anesthetic).
Unstandardized herbal extracts may interact pharmacodynamically with Tetracaine Hydrochloride maintenance therapy.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Tetracaine hydrochloride ophthalmic solution, 0.5% should not be used in patients with a history of hypersensitivity to any component of this preparation.
- Tetracaine hydrochloride ophthalmic solution, 0.5% should not be used in patients with a history of hypersensitivity to any component of this preparation.
Logged Side-Effect Incidence (19 Reports)
Tetracaine Hydrochloride Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Tetracaine Hydrochloride)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Benefits and safety of Combined skin-applied Lidocaine and Tetracaine Cream for This study demonstrated the equivalent efficacy of CU-30101 to its reference product, Pliaglis, among Chinese adults undergoing facial fractional laser resurfacing. Journal of cosmetic dermatology • 2025-08-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40735955 ↗ |
Tetracaine Hydrochloride Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $3.9931/unit (~$119.79/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $417.04 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 19 Anonymous DotMD Community Micro-Logs | $170.22 / mo | View logs ↓ |
Tetracaine Hydrochloride Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Tetracaine Hydrochloride RxNorm Concept ID | 1547771 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $3.9931 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $417.04 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $170.22 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 83.00% Worth It (19 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Tetracaine Hydrochloride Patient Community, Cohort Filters & Dosage Logs
Deterministic Tetracaine Hydrochloride reference combining NIH RxNorm (1547771), Medicaid NADAC ($3.9931/unit), and anonymous cohort outcomes (83% Worth It).
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Tetracaine Hydrochloride community threads and patient logs by age, biological sex, dosage, and treatment duration.